In value terms, private equity deal activity in The US increased by 959% in Q2 2023 compared with the previous quarter’s total of $217.1m and rose by 67% as compared to Q2 2022. Related deal volume increased by 31% in Q2 2023 versus the previous quarter and was 6% higher than in Q2 2022.

The top-ranked financial advisors supporting these private equity deals in The US in Q2 2023 were Piper Sandler Companies; Centerview Partners; Guggenheim Partners with 3, 1, 1 deals respectively.

The top-ranked legal advisorss supporting these private equity deals in The US Q2 2023 were Morgan, Lewis & Bockius; Wilson Sonsini Goodrich & Rosati Professional; Covington & Burling with 2, 2, 1 deals respectively.

For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.